Literature DB >> 12578086

Evaluation of hemostasis by the Clot Signature Analyzer: a potentially valuable device for the anesthesiologist.

A S Haddadin1, C M Ayoub, F B Sevarino, C S Rinder.   

Abstract

Rapid detection of hemostatic defects presents a challenge for the anesthesiologist who must balance anesthetic and surgical considerations for maintaining adequate platelet and coagulant factors, while keeping allogenic blood exposure to a minimum. The Clot Signature Analyzer, a point-of-care device capable of rapid response and easy interpretation is described here. Its applicability in two obstetrical patients with platelet dysfunction is discussed.

Entities:  

Mesh:

Year:  1999        PMID: 12578086     DOI: 10.1023/a:1009920622551

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  5 in total

1.  Use of thromboelastography in the management of von Willebrand's disease during cardiopulmonary bypass.

Authors:  K J Tuman; B D Spiess; R E Schoen; A D Ivankovich
Journal:  J Cardiothorac Anesth       Date:  1987-08

2.  Enhanced increases in cytosolic Ca2+ in ADP-stimulated platelets from patients with delta-storage pool deficiency--a possible indicator of interactions between granule-bound ADP and the membrane ADP receptor.

Authors:  B Lages; H J Weiss
Journal:  Thromb Haemost       Date:  1997-02       Impact factor: 5.249

3.  Comparison of thrombelastography with common coagulation tests.

Authors:  L Zuckerman; E Cohen; J P Vagher; E Woodward; J A Caprini
Journal:  Thromb Haemost       Date:  1981-12-23       Impact factor: 5.249

4.  Identification of a platelet dense granule membrane protein that is deficient in a patient with the Hermansky-Pudlak syndrome.

Authors:  J M Gerrard; D Lint; P J Sims; T Wiedmer; R D Fugate; E McMillan; C Robertson; S J Israels
Journal:  Blood       Date:  1991-01-01       Impact factor: 22.113

Review 5.  The Hermansky-Pudlak syndrome. Report of three cases and review of pathophysiology and management considerations.

Authors:  R A DePinho; K L Kaplan
Journal:  Medicine (Baltimore)       Date:  1985-05       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.